Jeopardized Myocardium and Survival in Patients Presenting to the Catheterization Laboratory With ST-Elevation

Francis R Joshi1, Frants Pedersen1, Sune Räder1

  • 1Department of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Denmark.

Insights

Myocardial jeopardy scores did not predict mortality in patients with ST-elevation myocardial infarction and cardiogenic shock. Further research is needed to understand why multi-vessel revascularization lacks clinical benefit in these high-risk patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Contemporary data challenge historical guidance on multi-vessel revascularization in ST-elevation myocardial infarction (STEMI) with cardiogenic shock.
  • Survival benefits of multi-vessel revascularization in this patient group remain unclear, necessitating further mechanistic investigation.

Purpose of the Study:

  • To investigate the relationship between the extent of jeopardized myocardium and mortality in patients with STEMI and cardiogenic shock.
  • To assess the predictive value of myocardial jeopardy scores in this high-risk population.

Main Methods:

  • Retrospective analysis of 128 patients with STEMI and cardiogenic shock undergoing primary percutaneous coronary intervention (PPCI) in Eastern Denmark (June 2011–December 2014).
  • Calculation of British Cardiovascular Intervention Society (BCIS)-1 jeopardy scores from angiography.
  • Evaluation of 30-day mortality as the primary endpoint.

Main Results:

  • 30-day mortality was 53.9%.
  • Predictors of mortality included increasing age, elevated lactate levels, mechanical ventilation, and low systolic blood pressure.
  • Successful reperfusion (TIMI 3 flow) post-PPCI was associated with reduced mortality.
  • Pre-PCI BCIS-1 jeopardy scores did not correlate with 30-day mortality.

Conclusions:

  • Myocardial jeopardy scores are not associated with patient outcomes in STEMI complicated by cardiogenic shock.
  • Jeopardy scores may be useful for analyzing existing data to elucidate the reasons behind the lack of survival benefit from multi-vessel revascularization in cardiogenic shock.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
665
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
188
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
176
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
318
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
311
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
934